TFPI Antikörper (AA 253-304)

Produktnummer ABIN5518873

Produktdetails anti-TFPI Antikörper

Target: TFPI (Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor) (TFPI))

Bindungsspezifität: AA 253-304

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TFPI Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Verwendungszweck: Rabbit IgG polyclonal antibody for Tissue factor pathway inhibitor(TFPI) detection. Tested with WB in Human.

Kreuzreaktivität (Details): No cross reactivity with other proteins.

Produktmerkmale: Rabbit IgG polyclonal antibody for Tissue factor pathway inhibitor(TFPI) detection. Tested with WB in Human.
Gene Name: tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
Protein Name: Tissue factor pathway inhibitor

Aufreinigung: Immunogen affinity purified.

Immunogen: E.coli-derived human TFPI recombinant protein (Position: N253-M304). Human TFPI shares 51.1% and 53.2% amino acid (aa) sequence identity with mouse and rat TFPI, respectively.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human
Notes: Tested Species: Species with positive results.
Other applications have not been tested. Optimal dilutions should be determined by end users.

Kommentare:

Antibody can be supported by chemiluminescence kit ABIN921124 in WB.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

Konzentration: 500 μg/mL

Buffer: Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.

Details zu TFPI

Target: TFPI (Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor) (TFPI))

Andere Bezeichnung: TFPI (TFPI Produkte)

Synonyme: EPI antikoerper, LACI antikoerper, TFI antikoerper, TFPI1 antikoerper, A630013F22Rik antikoerper, AW552122 antikoerper, TFPI antikoerper, si:dz44f8.1 antikoerper, tfpib antikoerper, wu:fb92g01 antikoerper, zgc:152844 antikoerper, zgc:158592 antikoerper, tissue factor pathway inhibitor antikoerper, tissue factor pathway inhibitor a antikoerper, TFPI antikoerper, Tfpi antikoerper, tfpia antikoerper

Hintergrund: TFPI (Tissue factor pathway inhibitor) also known as EPI, LACI, TFI and TFPT1 is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa) and Thrombin (Factor IIa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-tissue factor complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5 nM. The gene for TFPI is located on chromosome 2q31-q32.1, and has nine exons which span 70 kb. TFPI has a relative molecular mass of 34,000 to 40,000 depending on the degree of proteolysis of the C-terminal region.

Synonyms: Tissue factor pathway inhibitor | TFPI | Extrinsic pathway inhibitor | EPI | Lipoprotein-associated coagulation inhibitor | LACI | TFPI1 | P10646

Gen-ID: 7035

UniProt: P10646